113 related articles for article (PubMed ID: 9461166)
1. Therapeutic replication-competent herpes virus.
Rampling R; Cruickshank G; MacLean A; Brown M
Nat Med; 1998 Feb; 4(2):133. PubMed ID: 9461166
[No Abstract] [Full Text] [Related]
2. Phase ib trial of oncolytic herpes virus G207 shows safety of multiple injections and documents viral replication.
Aghi MK; Chiocca EA
Mol Ther; 2009 Jan; 17(1):8-9. PubMed ID: 19116635
[No Abstract] [Full Text] [Related]
3. The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study.
Papanastassiou V; Rampling R; Fraser M; Petty R; Hadley D; Nicoll J; Harland J; Mabbs R; Brown M
Gene Ther; 2002 Mar; 9(6):398-406. PubMed ID: 11960316
[TBL] [Abstract][Full Text] [Related]
4. Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM.
Markert JM; Liechty PG; Wang W; Gaston S; Braz E; Karrasch M; Nabors LB; Markiewicz M; Lakeman AD; Palmer CA; Parker JN; Whitley RJ; Gillespie GY
Mol Ther; 2009 Jan; 17(1):199-207. PubMed ID: 18957964
[TBL] [Abstract][Full Text] [Related]
5. Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial.
Prados MD; McDermott M; Chang SM; Wilson CB; Fick J; Culver KW; Van Gilder J; Keles GE; Spence A; Berger M
J Neurooncol; 2003 Dec; 65(3):269-78. PubMed ID: 14682377
[TBL] [Abstract][Full Text] [Related]
6. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group.
Shand N; Weber F; Mariani L; Bernstein M; Gianella-Borradori A; Long Z; Sorensen AG; Barbier N
Hum Gene Ther; 1999 Sep; 10(14):2325-35. PubMed ID: 10515452
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of brain tumors using neural stem cells and replication-conditional virus].
Yazaki T; Kanai R; Kawase T
Nihon Rinsho; 2005 Sep; 63 Suppl 9():551-6. PubMed ID: 16201580
[No Abstract] [Full Text] [Related]
8. Recurrent brainstem encephalitis associated with herpes simplex virus type 1 DNA in cerebrospinal fluid.
Tyler KL; Tedder DG; Yamamoto LJ; Klapper JA; Ashley R; Lichtenstein KA; Levin MJ
Neurology; 1995 Dec; 45(12):2246-50. PubMed ID: 8848201
[TBL] [Abstract][Full Text] [Related]
9. Cure following gene therapy for recurrent glioblastoma multiforme?
Karabatsou K; Bernstein M
Acta Neurochir (Wien); 2008 Jun; 150(6):611-2. PubMed ID: 18511998
[TBL] [Abstract][Full Text] [Related]
10. Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/ganciclovir gene therapy.
Izquierdo M; Martín V; de Felipe P; Izquierdo JM; Pérez-Higueras A; Cortés ML; Paz JF; Isla A; Blázquez MG
Gene Ther; 1996 Jun; 3(6):491-5. PubMed ID: 8789798
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia enhances the replication of oncolytic herpes simplex virus.
Aghi MK; Liu TC; Rabkin S; Martuza RL
Mol Ther; 2009 Jan; 17(1):51-6. PubMed ID: 18957963
[TBL] [Abstract][Full Text] [Related]
12. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.
Mineta T; Rabkin SD; Yazaki T; Hunter WD; Martuza RL
Nat Med; 1995 Sep; 1(9):938-43. PubMed ID: 7585221
[TBL] [Abstract][Full Text] [Related]
13. UV-enhanced replication of herpes simplex virus in DNA-repair competent and deficient fibroblasts.
Miller CS; Jacob RJ; Hiser DG
Oral Surg Oral Med Oral Pathol; 1993 May; 75(5):602-9. PubMed ID: 8387663
[TBL] [Abstract][Full Text] [Related]
14. [Latent infection and recurrent disease caused by herpes simplex type 1: prophylactic and therapeutic perspectives].
Berría MI
Medicina (B Aires); 1986; 46(2):225-34. PubMed ID: 3033427
[No Abstract] [Full Text] [Related]
15. Herpes vector-mediated gene transfer in treatment of diseases of the nervous system.
Glorioso JC; Fink DJ
Annu Rev Microbiol; 2004; 58():253-71. PubMed ID: 15487938
[TBL] [Abstract][Full Text] [Related]
16. [Herpes simplex virus DNA replication].
Tsurumi T
Tanpakushitsu Kakusan Koso; 1992 Oct; 37(14 Suppl):2519-31. PubMed ID: 1332121
[No Abstract] [Full Text] [Related]
17. Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect.
Fu X; Tao L; Jin A; Vile R; Brenner MK; Zhang X
Mol Ther; 2003 Jun; 7(6):748-54. PubMed ID: 12788648
[TBL] [Abstract][Full Text] [Related]
18. The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors.
Roizman B
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11307-12. PubMed ID: 8876131
[TBL] [Abstract][Full Text] [Related]
19. Antitumoral effects of defective herpes simplex virus-mediated transfer of tissue inhibitor of metalloproteinases-2 gene in malignant glioma U87 in vitro: consequences for anti-cancer gene therapy.
Hoshi M; Harada A; Kawase T; Uyemura K; Yazaki T
Cancer Gene Ther; 2000 May; 7(5):799-805. PubMed ID: 10830727
[TBL] [Abstract][Full Text] [Related]
20. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
